Senior insider sale
Chief Financial Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$41.0K
8.76K shares
What this filing means
TAMAYO LOUIS EDWARD plans to sell 8.76K shares of LEXEO THERAPEUTICS, INC. valued at approximately $41.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001959173-26-006152
Officer· Chief Financial Officer
Since Feb 2026
8.76K
Shares to sell
$41.0K
Approx. market value
4.12K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/17/2026
4.12KTotal acquired4.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Restricted Stock Vesting Compensation | 4.12K | — |
| Total | 4.12K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.64K
Market value
$20.8K
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.12K
Market value
$20.2K
8/18/2026
Total
Units
8.76K
Value
$41.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 4.64K | $20.8K | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 4.12K | $20.2K | NASDAQ | Planned |
| Total | 8.76K | $41.0K | ||